Status:
UNKNOWN
Intraoperative ADSC Administration During Nerve Release
Lead Sponsor:
Mossakowski Medical Research Centre Polish Academy of Sciences
Collaborating Sponsors:
Centre of Postgraduate Medical Education
Conditions:
Neurotmesis of Peripheral Nerve (Disorder)
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
The goal of the investigator's observational, nonrandomized, open label study is to investigate the safety and efficacy of autologous adipose derived mesenchymal cells (ADSC) transplantation into the ...
Detailed Description
The aim of the study will be an evaluation of undifferentiated Adipose-Derived Stromal/Stem Cells (ADSC) usage during a last-chance surgery (neurolysis, nerve release) on a previously reconstructed ne...
Eligibility Criteria
Inclusion
- clinically definite failure nerve reconstructed patients
- lack of improvement after previous treatment
- without severe, unstable chronic diseases
- Polish citizens
Exclusion
- INR \> 2 before liposuction
- primary haematological disease, including hypercoagulable states
- previous/current history of neoplasm or comorbidity that could impact upon patient's survival
- pregnancy /lactation
- alcohol abuse, cocaine amphetamine, etc.
Key Trial Info
Start Date :
April 23 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 23 2022
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04346680
Start Date
April 23 2014
End Date
June 23 2022
Last Update
April 15 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.